Predicting Vaccine Hesitancy Using Machine Learning
Launched by UNIVERSITY OF YALOVA · May 23, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Predicting Vaccine Hesitancy Using Machine Learning," is focused on understanding why some parents may be hesitant to vaccinate their young children, specifically those aged 0 to 4 years. The study aims to use advanced computer techniques called machine learning to analyze patterns in data that can help predict which parents might refuse vaccinations. By identifying these factors, researchers hope to create strategies that can better encourage vaccination among families who may be at risk of hesitancy.
To participate in this trial, parents must be at least 18 years old, understand Turkish, and be comfortable using technology like smartphones or computers to communicate via social media. They should also have children aged 0 to 4 years who do not have any serious health issues that would prevent them from getting vaccinated. Participants will be helping researchers gain valuable insights into vaccine hesitancy, which could ultimately support public health efforts to ensure more children receive their vaccinations on time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Parents who meet the following criteria will be included in the study:
- • Have proficiency in understanding and reading the Turkish language,
- • Are able to use technological devices such as mobile phones or computers to access social media platforms (Participants used social media platforms such as Instagram and WhatsApp to communicate) via the internet,
- • Are 18 years of age or older,
- • Have children aged 0-4 years,
- • Consent to participate in the study,
- • Have children without any absolute contraindications to vaccination.
- Exclusion Criteria:
- • Parents of high-risk infants (such as those with a history of systemic illness, preterm labor, anomalies, etc.),
- • Parents who are unwilling to participate in the study will be excluded.
About University Of Yalova
The University of Yalova, a prominent academic institution located in Turkey, is dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at improving healthcare outcomes and contributing to the scientific community. Its research initiatives are supported by a team of experienced professionals and state-of-the-art facilities, fostering a robust environment for the development and evaluation of novel therapeutic interventions. Through these efforts, the University of Yalova strives to enhance patient care and promote evidence-based practices in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yalova, , Turkey
Patients applied
Trial Officials
EMEL AVÇİN, Assist Prof
Principal Investigator
Yalova Unıversıty
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported